Medline Stock Soars 12%, Adding $3.6 Billion, After Raising Sales Outlook And Authorizing Buyback
The medical supplier lifted its organic sales growth forecast and approved a $1 billion repurchase alongside third-quarter results.
Medline, which makes and distributes medical-surgical supplies for hospitals and other care sites, saw its shares climb 12.03% to $38.19 in Wednesday trading, as of 9:59 a.m. ET, adding $3.6 billion in market value. The company raised its full-year organic sales growth forecast and its board approved a $1 billion buyback alongside third-quarter results.
Sales up, profit slightly down
Sales grew 10.4% to $7.9 billion, per the filing, but profit was $318 million, down 1.2%.
Adjusted EBITDA, an adjusted earnings measure, reached $960 million, up 11.8%. Tariff refunds contributed $81 million to the quarter.
Medline now expects organic sales growth of 10.0% to 10.5% for the year, up from a prior range of 9.0% to 10.0%. It held its annual adjusted EBITDA range of $3.3 billion to $3.4 billion.
Fire loss and tariff refunds
For the first nine months, profit fell 28.8% to $696 million. A $316 million loss from a fire at its Tracy, California, facility helps explain the drop.
Nine-month refunds totaled $324 million.
A stock down 19% this year
Medline sells its own-brand products, such as wound care, exam gloves and surgical procedure trays, and distributes other suppliers' goods, with many customers on multi-year Prime Vendor agreements. It offers about 335,000 products across 70 distribution and related facilities and 30 manufacturing facilities, according to its annual report.
The stock was down about 19% year to date at Tuesday's close, while the S&P 500 was up about 11%. Wednesday's move put it on pace for a fourth straight daily gain and its biggest one-day gain in at least 220 trading sessions, since Dec. 18, 2025.
The company's market value stood at $33.5 billion in Wednesday morning trading.
Sources
- Medline: Q3 Earnings Snapshot – WTOP News — wtop.com
- Medline: Q3 Earnings Snapshot — Associated Press
- Medline Industries Inc. : Cases :: Law360 — law360.com
- Medline: Q3 Earnings Snapshot | wfaa.com — Associated Press
- Medline Reports Third Quarter and Nine Months 2026 Results — globenewswire.com
- The company's filing (Medline) — SEC filing
- Medline — Form 10-K for the fiscal year ended 2025-12-31 (quarterly results) — SEC EDGAR